GBIO Generation Bio Co.

Nasdaq generationbio.com


$ 5.64 $ 0.08 (1.44 %)    

Thursday, 13-Nov-2025 15:59:45 EST
QQQ $ 608.59 $ -9.26 (-1.5 %)
DIA $ 475.50 $ -6.59 (-1.37 %)
SPY $ 672.57 $ -8.41 (-1.24 %)
TLT $ 89.38 $ -0.42 (-0.46 %)
GLD $ 384.40 $ -4.31 (-1.11 %)
$ 5.62
$ 5.50
$ 5.49 x 500
$ 5.88 x 140
$ 5.50 - $ 5.89
$ 3.00 - $ 18.60
166,947
na
37.87M
$ 2.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-12-2025 06-30-2025 10-Q
3 05-07-2025 03-31-2025 10-Q
4 03-13-2025 12-31-2024 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-06-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-02-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 02-23-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 02-24-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-11-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
20 03-18-2021 12-31-2020 10-K
21 11-10-2020 09-30-2020 10-Q
22 08-11-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 generation-bio-q3-eps-082-beats-317-estimate-sales-1594m-beat-660000k-estimate

Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(0.82) per share which beat the analyst consensus estimate of $(3.17...

 generation-bio-president-ceo-geoff-mcdonough-to-become-board-chair-effective-oct-31-yalonda-howze-names-interim-ceo-president

Generation Bio Co. (NASDAQ:GBIO), a biotechnology company working to change what's possible for people living with T cell-d...

 needham-reiterates-buy-on-generation-bio-maintains-15-price-target

Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $15 price target.

 wedbush-downgrades-generation-bio-to-neutral-maintains-price-target-to-7

Wedbush analyst David Nierengarten downgrades Generation Bio (NASDAQ:GBIO) from Outperform to Neutral and maintains the pric...

 why-sapiens-international-shares-are-trading-higher-by-around-44-here-are-20-stocks-moving-premarket

Shares of Sapiens International Corporation NV (NASDAQ:SPNS) rose sharply in pre-market trading after it announced on Wednesday...

 generation-bio-q2-eps-312-misses-262-estimate-sales-765000k-miss-2139m-estimate

Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(3.12) per share which missed the analyst consensus estimate of $(2....

 generation-bio-has-been-granted-australian-patent-number-2019210034-titled-closed-ended-dna-vectors-obtainable-from-cell-free-synthesis-and-process-for-obtaining-cedna-vectors-for-gene-therapy

https://ipsearch.ipaustralia.gov.au/patents/2019210034

 needham-reiterates-buy-on-generation-bio-maintains-8-price-target

Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $8 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION